Articles Tagged With:
-
Cardholders May Be Protected
"Cardholders” — those who are legally allowed to use medical marijuana — should be handled carefully in states that specifically prohibit discrimination against them.
-
Is There an Optimal Blood Pressure Target in Patients Presenting with Intracerebral Hemorrhage?
Recently, two large randomized, controlled trials compared intensive blood pressure control with permissive hypertension in the setting of acute intracerebral hemorrhage. The authors of the two trials reached seemingly differing conclusions, leading to confusion on how to best manage patients.
-
Legal Marijuana Requires Reassessing Hospital Drug Policies
Changing state laws regarding marijuana are forcing healthcare providers to reconsider their policies on drug use by employees. Risk managers should review their policies in light of labor laws and patient safety.
-
Troponin Highly Prognostic in Decompensated Heart Failure with Preserved Ejection Fraction
Among patients with acute decompensated heart failure and preserved ejection fraction, elevated troponin is associated with worse in-hospital outcomes and long-term survival, independent of other predictors.
-
Utility of Serial Coronary Calcium Scores
Researchers determined recently that if serial scans are performed, the most recent scan should be used for risk assessment, and the degree of CT calcium score progression adds no further prognostic information.
-
A New Risk Score for Stroke in Atrial Fibrillation
A new, simpler score for stroke risk prediction in atrial fibrillation patients uses biomarkers to supplant many clinical variables and outperforms the CHA2DS2-VASc score in two large cohorts.
-
Orbiting the Truth of Heart Failure Incidence and Implications in Those with Prevalent Atrial Fibrillation
Patients presenting with atrial fibrillation are at elevated risk for the development of heart failure, typically with preserved ejection fraction, which is associated with increased risk of death and hospitalization.
-
NOACs in Patients Requiring Anticoagulation Post-PCI
In patients with atrial fibrillation post-percutaneous coronary intervention with stent placement, recently studied regimens conferred a significantly lower risk of clinically important bleeding compared to standard triple therapy with full-dose warfarin.
-
Life Safety Code 2012: Changes You Need to Know
Does your hospital have what it takes to comply with CMS Hospital CoPs? -
Sacubitril/Valsartan Associated with Reduced Risk of Hyperkalemia
\In a secondary analysis of the PARADIGM-HF trial, the risk of severe hyperkalemia in heart failure patients taking a mineralocorticoid receptor antagonist was lower among patients treated with sacubitril/valsartan compared to those receiving enalapril.